Generic Fosamax Available
February 10, 2008 by MedHeadlines
Filed under Drugs, FDA, Headlines, Osteoporosis
The FDA has approved the first generic version of Fosamax (alendronate). The generic drug will be available in once-daily tablets (5 mg, 10 mg, and 40 mg) and once-weekly tablets (35 mg and 70 mg). Teva Pharmaceuticals USA received clearance to produce 5 mg, 10 mg, 40 mg once-daily tablets and 35 mg, 70 mg once-weekly tablets. Barr Laboratories was approved to make 70 mg once-weekly tablets. Read more
Loading ...
